Granules India Ltd

Granules India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Granules India Ltd

₹ 424 1.46%
26 Apr - close price
granulesindia.com BSE: 532482 NSE : GRANULES
About

Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.[1]

Key Points

Business Segments FY23

Website BSE NSE
  • Market Cap ₹ 10,278 Cr.
  • Current Price ₹ 424
  • High / Low ₹ 480 / 272
  • Stock P/E 22.2
  • Book Value ₹ 118
  • Dividend Yield 0.35 %
  • ROCE 19.5 %
  • ROE 19.1 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company's median sales growth is 21.4% of last 10 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
776 782 732 704 890 913 921 964 1,032 1,014 821 1,009 984
575 559 582 610 698 707 725 778 794 797 664 801 738
Operating Profit 201 223 150 93 192 206 197 186 239 217 157 208 247
OPM % 26% 29% 20% 13% 22% 23% 21% 19% 23% 21% 19% 21% 25%
3 3 7 4 5 4 5 4 -1 3 0 1 1
Interest 6 6 5 4 3 4 4 8 12 14 15 18 20
Depreciation 30 31 32 32 31 32 35 35 38 38 35 36 36
Profit before tax 169 190 121 62 163 175 162 146 188 168 107 156 192
Tax % 22% 25% 25% 25% 25% 26% 23% 25% 25% 25% 25% 26% 26%
131 142 90 46 121 129 125 109 140 125 80 116 143
EPS in Rs 5.29 5.74 3.63 1.86 4.89 5.21 5.03 4.39 5.78 5.18 3.30 4.79 5.89
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
563 677 990 1,213 1,328 1,349 1,647 2,098 2,310 3,135 3,238 3,931 3,829
490 598 826 1,001 1,058 1,054 1,353 1,766 1,816 2,273 2,589 3,092 2,999
Operating Profit 73 79 163 212 270 296 294 333 494 862 649 840 829
OPM % 13% 12% 16% 17% 20% 22% 18% 16% 21% 27% 20% 21% 22%
1 2 3 1 6 15 24 28 187 13 13 9 5
Interest 15 16 19 31 37 32 33 28 27 24 16 39 66
Depreciation 18 20 26 50 58 71 76 91 102 118 126 146 145
Profit before tax 40 44 121 132 181 207 208 242 553 733 520 664 623
Tax % 32% 32% 33% 28% 33% 31% 33% 33% 20% 25% 26% 25%
27 30 81 95 121 143 139 162 444 553 387 499 464
EPS in Rs 1.36 1.50 3.99 4.66 5.57 6.25 5.48 6.37 17.47 22.32 15.59 20.61 19.16
Dividend Payout % 15% 13% 9% 11% 12% 14% 18% 16% 6% 7% 10% 7%
Compounded Sales Growth
10 Years: 19%
5 Years: 19%
3 Years: 19%
TTM: 0%
Compounded Profit Growth
10 Years: 32%
5 Years: 29%
3 Years: 16%
TTM: -8%
Stock Price CAGR
10 Years: 28%
5 Years: 30%
3 Years: 9%
1 Year: 41%
Return on Equity
10 Years: 19%
5 Years: 19%
3 Years: 21%
Last Year: 19%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 20 20 20 20 22 23 25 25 25 25 25 24 24
Reserves 225 251 324 405 643 861 1,253 1,398 1,786 2,138 2,506 2,675 2,845
163 227 330 412 641 656 978 991 891 849 1,061 923 1,164
99 119 181 270 262 314 382 410 444 672 781 881 819
Total Liabilities 507 617 856 1,107 1,568 1,855 2,639 2,824 3,146 3,683 4,373 4,503 4,853
237 245 336 522 523 606 660 700 927 985 1,171 1,330 1,297
CWIP 29 92 39 18 35 132 286 333 130 164 211 63 87
Investments 33 51 145 72 89 75 75 506 445 592 597 677 818
208 230 336 494 920 1,042 1,618 1,285 1,644 1,942 2,395 2,433 2,651
Total Assets 507 617 856 1,107 1,568 1,855 2,639 2,824 3,146 3,683 4,373 4,503 4,853

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
39 51 94 135 144 190 24 227 495 375 280 664
-65 -112 -159 -130 -171 -299 -495 -243 -165 -233 -318 -97
42 43 80 25 86 36 529 -17 -212 -296 151 -519
Net Cash Flow 17 -17 16 30 58 -73 58 -33 118 -154 114 48

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 34 37 45 58 122 127 154 122 99 118 136 127
Inventory Days 91 95 75 93 105 132 92 92 103 112 123 100
Days Payable 66 73 79 95 89 116 105 81 96 123 126 126
Cash Conversion Cycle 59 58 41 56 139 142 140 133 105 107 133 102
Working Capital Days 49 57 50 46 124 133 166 132 115 107 141 119
ROCE % 15% 13% 24% 22% 20% 17% 13% 12% 16% 26% 16% 20%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
42.04% 42.04% 41.98% 41.98% 41.98% 41.93% 42.02% 42.02% 42.02% 41.97% 41.97% 41.96%
18.35% 21.18% 21.38% 23.19% 23.13% 22.35% 23.66% 23.90% 21.35% 21.48% 18.78% 19.57%
2.86% 2.77% 4.34% 3.98% 3.03% 4.32% 4.75% 5.03% 6.68% 7.06% 10.16% 10.70%
36.76% 34.01% 32.30% 30.85% 31.85% 31.40% 29.56% 29.05% 29.95% 29.51% 29.10% 27.77%
No. of Shareholders 2,61,1652,39,5202,16,3852,10,7852,14,5392,16,0551,90,8941,87,7772,01,0542,07,0551,90,6911,82,142

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls